File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.2147/DDDT.S72797
- Scopus: eid_2-s2.0-84929162264
- PMID: 25429204
- WOS: WOS:000344925200001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Choosing preclinical study models of diabetic retinopathy: key problems for consideration
Title | Choosing preclinical study models of diabetic retinopathy: key problems for consideration |
---|---|
Authors | |
Keywords | Animal model Ex vivo culture In vitro culture Neurovascular dysfunction |
Issue Date | 2014 |
Publisher | Dove Medical Press Ltd. The Journal's web site is located at http://www.dovepress.com/articles.php?issue_id=142 |
Citation | Drug Design, Development and Therapy, 2014, v. 8, p. 2311-2319 How to Cite? |
Abstract | Diabetic retinopathy (DR) is the most common complication of diabetes mellitus in the eye. Although the clinical treatment for DR has already developed to a relative high level, there are still many urgent problems that need to be investigated in clinical and basic science. Currently, many in vivo animal models and in vitro culture systems have been applied to solve these problems. Many approaches have also been used to establish different DR models. However, till now, there has not been a single study model that can clearly and exactly mimic the developmental process of the human DR. Choosing the suitable model is important, not only for achieving our research goals smoothly, but also, to better match with different experimental proposals in the study. In this review, key problems for consideration in choosing study models of DR are discussed. These problems relate to clinical relevance, different approaches for establishing models, and choice of different species of animals as well as of the specific in vitro culture systems. Attending to these considerations will deepen the understanding on current study models and optimize the experimental design for the final goal of preventing DR. |
Persistent Identifier | http://hdl.handle.net/10722/208786 |
ISSN | 2023 Impact Factor: 4.7 2023 SCImago Journal Rankings: 0.999 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mi, X | - |
dc.contributor.author | Yuan, TF | - |
dc.contributor.author | Ding, Y | - |
dc.contributor.author | Zhong, JX | - |
dc.contributor.author | So, KF | - |
dc.date.accessioned | 2015-03-18T09:13:02Z | - |
dc.date.available | 2015-03-18T09:13:02Z | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | Drug Design, Development and Therapy, 2014, v. 8, p. 2311-2319 | - |
dc.identifier.issn | 1177-8881 | - |
dc.identifier.uri | http://hdl.handle.net/10722/208786 | - |
dc.description.abstract | Diabetic retinopathy (DR) is the most common complication of diabetes mellitus in the eye. Although the clinical treatment for DR has already developed to a relative high level, there are still many urgent problems that need to be investigated in clinical and basic science. Currently, many in vivo animal models and in vitro culture systems have been applied to solve these problems. Many approaches have also been used to establish different DR models. However, till now, there has not been a single study model that can clearly and exactly mimic the developmental process of the human DR. Choosing the suitable model is important, not only for achieving our research goals smoothly, but also, to better match with different experimental proposals in the study. In this review, key problems for consideration in choosing study models of DR are discussed. These problems relate to clinical relevance, different approaches for establishing models, and choice of different species of animals as well as of the specific in vitro culture systems. Attending to these considerations will deepen the understanding on current study models and optimize the experimental design for the final goal of preventing DR. | - |
dc.language | eng | - |
dc.publisher | Dove Medical Press Ltd. The Journal's web site is located at http://www.dovepress.com/articles.php?issue_id=142 | - |
dc.relation.ispartof | Drug Design, Development and Therapy | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Animal model | - |
dc.subject | Ex vivo culture | - |
dc.subject | In vitro culture | - |
dc.subject | Neurovascular dysfunction | - |
dc.title | Choosing preclinical study models of diabetic retinopathy: key problems for consideration | - |
dc.type | Article | - |
dc.identifier.email | Mi, X: mxsong@hku.hk | - |
dc.identifier.email | Yuan, TF: tfyuan@hku.hk | - |
dc.identifier.email | So, KF: hrmaskf@hku.hk | - |
dc.identifier.authority | So, KF=rp00329 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.2147/DDDT.S72797 | - |
dc.identifier.pmid | 25429204 | - |
dc.identifier.pmcid | PMC4242133 | - |
dc.identifier.scopus | eid_2-s2.0-84929162264 | - |
dc.identifier.hkuros | 242710 | - |
dc.identifier.volume | 8 | - |
dc.identifier.spage | 2311 | - |
dc.identifier.epage | 2319 | - |
dc.identifier.isi | WOS:000344925200001 | - |
dc.publisher.place | New Zealand | - |
dc.identifier.issnl | 1177-8881 | - |